Form 4 for LNAI Lunai Bioworks Inc.
Accepted 2023-03-21 00:00:00 ET · period of report 2023-03-17 · accession 0001731122-23-000444 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2023-03-21 | 2023-03-17 | LNAI | Sindlev Rene | Dir, 10% | A - Grant | $1.14 | +877.2K | 10.55M | +9% | +$1.00M |
| DI | 2023-03-21 | 2023-03-17 | LNAI | Sindlev Rene | Dir, 10% | A - Grant | $0.00 | +438.6K | 438.6K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-17 | A | A | 877,193 | $1.14 | 10,545,544 | I By RS Bio ApS | — | — | |
| 2 | Derivative | Warrant (Right to Buy) | 2023-03-17 | A | A | 438,597 | $0.00 | 438,597 | I By RS Bio ApS | $1.14 · 2023-03-17 to 2028-03-17 | 438,597 Common Stock | (F1) Granted to the Reporting Person as warrant coverage in connection with the common stock reported on Table I. |